TickerFacts.

Company research / NPCE

NeuroPace Inc (NPCE)

Build a valuation ↗↓ Download CSV

CIK 0001528287 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, NeuroPace Inc reported revenue of $99.99M. Revenue grew 25.1% from the prior annual period.

Key ratios (year ended 2025-12-31)

77.2%
Gross margin
-16.3%
Operating margin
-21.5%
Net margin
-112.8%
Return on year-end equity
25.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-25

Headquarters locality: Mountain View · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Revenuen/a$99.99M$79.91M$65.42M$45.52M$45.18M$41.14M
Cost of Revenuen/a$22.77M$20.82M$17.30M$13.03M$11.75M$10.87M
Gross Profitn/a$77.22M$59.09M$48.12M$32.49M$33.44M$30.27M
R&D Expense$27.69M$27.89M$23.65M$20.78M$21.95M$18.21M$15.70M
Operating Incomen/a-$16.34M-$21.67M-$27.17M-$40.79M-$23.74M-$13.05M
Net Income-$19.11M-$21.46M-$27.14M-$32.96M-$47.08M-$36.08M-$24.28M
EPS (Diluted)n/a-$0.66-$0.93-$1.27-$1.91-$2.17-$117.85
Total Assets$96.99M$105.56M$94.65M$107.65M$114.11M$133.56M$55.95M
Total Liabilities$85.11M$86.53M$86.63M$87.00M$79.33M$60.06M$62.36M
Shareholders' Equity$11.88M$19.03M$8.01M$20.65M$34.78M$73.50M-$147.83M
Cash & Equivalents$12.54M$21.69M$13.43M$18.06M$6.61M$19.19M$26.39M
Operating Cash Flow-$11.24M-$11.01M-$17.95M-$19.70M-$36.87M-$24.58M-$21.61M
Capital Expenditures$369.0K$332.0K$306.0K$173.0K$603.0K$384.0K$62.0K
Free Cash Flow-$11.61M-$11.34M-$18.25M-$19.87M-$37.47M-$24.96M-$21.67M
Share Repurchases$0$49.55M$0n/an/an/an/a
Shares Outstanding34.28M33.57M30.15M27.82M25.05M24.45M314.1K
Dividends Per Sharen/a$0.00$0.00$0.00n/an/an/a
Weighted Average Diluted Sharesn/a32.72M29.13M25.85M24.59M16.61M204.1K
EPS (Basic)n/a-$0.66-$0.93-$1.27-$1.91-$2.17-$117.85

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView